These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36931982)

  • 1. A scoping review of empirical research on prescription drug promotion.
    Giombi K; Thompson J; Wines C; Haughney R; Sullivan HW; Betts KR
    Res Social Adm Pharm; 2023 Jun; 19(6):859-872. PubMed ID: 36931982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What influences healthcare providers' prescribing decisions? Results from a national survey.
    Price SM; O'Donoghue AC; Rizzo L; Sapru S; Aikin KJ
    Res Social Adm Pharm; 2021 Oct; 17(10):1770-1779. PubMed ID: 33558154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation.
    Li S; Gibbs I
    J Pharm Pharm Sci; 2021; 24():381-389. PubMed ID: 34314671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions.
    Sullivan HW; Aikin KJ; Berktold J; Stein KL; Hoverman VJ
    J Am Board Fam Med; 2020; 33(2):279-283. PubMed ID: 32179611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
    Eisenberg MD; Singh Y; Sood N
    JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Doran E
    Int J Health Policy Manag; 2016 Feb; 5(5):333-5. PubMed ID: 27239884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.
    DiStefano MJ; Markell JM; Doherty CC; Alexander GC; Anderson GF
    JAMA; 2023 Feb; 329(5):386-392. PubMed ID: 36749334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.
    DeFrank JT; Berkman ND; Kahwati L; Cullen K; Aikin KJ; Sullivan HW
    Health Commun; 2020 May; 35(6):739-746. PubMed ID: 30973021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scoping review on disparities in exposure to advertising for e-cigarettes and heated tobacco products and implications for advancing a health equity research agenda.
    Grilo G; Crespi E; Cohen JE
    Int J Equity Health; 2021 Oct; 20(1):238. PubMed ID: 34717629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM; Cevasco M; Rosenthal MB
    N Engl J Med; 2007 Aug; 357(7):673-81. PubMed ID: 17699817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B
    Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration.
    Sullivan HW; Aikin KJ; Chung-Davies E; Wade M
    PLoS One; 2016; 11(5):e0155035. PubMed ID: 27149513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence.
    Im H; Huh J
    Res Social Adm Pharm; 2022 Jul; 18(7):3119-3130. PubMed ID: 34454872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.